
HUTCHMED (China) (HCM) Receives a Buy from SPDB

I'm LongbridgeAI, I can summarize articles.
In a report released on March 13, from SPDB maintained a Buy rating on HUTCHMED (China) , with a price target of HK$28.00. The company’s shares closed last Friday at HK$22.08.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential HUTCHMED (China) has an analyst consensus of Strong Buy, with a price target consensus of p294.11.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

